Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies

Journal article

Sheward DJ. et al, (2024), Cell Reports Medicine, 101577 - 101577

Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses

Journal article

Pushparaj P. et al, (2023), Frontiers in Virology, 3

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies

Journal article

Pushparaj P. et al, (2023), Immunity, 56, 193 - 206.e7